News
RVNC
3.780
-0.26%
-0.010
AbbVie working with FDA after reports of fake Botox versions
Seeking Alpha · 3d ago
Weekly Report: what happened at RVNC last week (0408-0412)?
Weekly Report · 4d ago
Revance To Present New DAXXIFY Data At The American Academy Of Neurology 2024 Annual Meeting
Revance Therapeutics, Inc. Will present two poster presentations on DAXXIFY® for the treatment of cervical dystonia at the annual meeting of American Academy of Neurology in 2024. A new analysis from ASPEN trials shows 50% of peak efficacy remained at the time of request for early retreatment. A second abstract examines the influence of DAXXify's formulation on clinical performance. The long-acting symptom control allows physicians to customize treatment intervals.
Benzinga · 04/12 12:01
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Shares of BlackBerry Limited jumped 9% to $3.1340 on Tuesday. The company announced a collaboration with Advanced Micro Devices, Inc. The Dow Jones index fell over 200 points in today’s session. Other big U.S. Stocks were also lower.
Benzinga · 04/09 14:43
Weekly Report: what happened at RVNC last week (0401-0405)?
Weekly Report · 04/08 10:53
Weekly Report: what happened at RVNC last week (0325-0329)?
Weekly Report · 04/01 10:51
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Revance Therapeutics, Inc. Announced new hire grants totaling an aggregate of 222,452 inducement restricted stock units to 29 employees. The RSUs vest over four years, with 25% of the underlying shares vesting on each anniversary. Revance is a biotechnology company setting the new standard in healthcare.
Barchart · 03/27 15:05
Weekly Report: what happened at RVNC last week (0318-0322)?
Weekly Report · 03/25 10:54
Revance Therapeu: Report of proposed sale of securities
Press release · 03/18 14:16
Weekly Report: what happened at RVNC last week (0311-0315)?
Weekly Report · 03/18 10:52
Survey finds GLP-1 users more inclined to get aesthetic procedures
Seeking Alpha · 03/17 21:09
Weekly Report: what happened at RVNC last week (0304-0308)?
Weekly Report · 03/11 10:50
Revance stock rises after CEO discloses share purchase
Revance stock rises after CEO discloses share purchase by its CEO Mark J Foley. Foley bought 30,000 shares of the common stock in an underwritten public offering that closed on March 6, 2024. Shares of Revance Therapeutics jumped over 9% in early trading.
Seeking Alpha · 03/11 10:37
GDS Holdings, Coinbase And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Shares of GDS Holdings Limited (NASDAQ:GDS) rose sharply in today’s pre-market trading. The Dow futures fell by around 100 points on Monday. U.S. Stock futures were lower this morning, with the Dow futures falling by around 200 points. GDS shares jumped 17.7% to $7.54 in today's pre- market trading.
Benzinga · 03/11 09:50
Stocks to Watch: Graphite Bio, Revance Therapeutics
Graphite Bio on Friday said it would pay a special dividend tied to its merger with Lenz Therapeutics. Shares of the biotechnology company climbed 10% to $3.46 in after-hours trading. Revance Therapeutic said its chief executive bought additional shares in the company.
Dow Jones · 03/08 23:54
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Bitdeer Technologies Group shares jumped 10.2% to $7.45 on Monday. The company announced successful testing of its SEAL01 Bitcoin mining chip. BitFuFu Inc. Shares jumped 107% in the mid-day session. Macy's, Inc. And MGE also rose amid strength in the price of Bitcoin.
Benzinga · 03/04 18:29
Revance Prices Offering Of 16 Mln Shares At $6.25/Share; Stock Drops
NASDAQ · 03/04 16:06
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Shares of Tesla, Inc. (NASDAQ:TSLA) fell 5.4% to $191.79 on Monday. The company reportedly saw a decline in February China sales. The Dow Jones index fell around 80 points in today's session. Other big U.S. Stocks recording losses include MMTec, Victoria's Secret and Spirit Airlines.
Benzinga · 03/04 15:40
Revance Therapeutics Shares Slide After Public Offering
Revance Therapeutics is selling 16 million shares at $6.25 apiece. The biotechnology company is raising $100 million in a public stock offering. The company says it plans to use proceeds to advance its aesthetics portfolio. Revance shares are down more than 10% on Monday.
Dow Jones · 03/04 14:49
BUZZ-Revance Therapeutics drops after $100 mln stock offering prices
Shares of Revance Therapeutics down 10.7% at $6.23 on Mon after equity offering prices. Aesthetic drug maker sells 16 mln shares for $100 mln. Shares surged 26% last week after Q4 rev of $69.8m.
Reuters · 03/04 14:47
More
Webull provides a variety of real-time RVNC stock news. You can receive the latest news about Revance Therapeu through multiple platforms. This information may help you make smarter investment decisions.
About RVNC
Revance Therapeutics, Inc. is a biotechnology company focused on developing and commercializing aesthetic and therapeutic offerings. The Company's portfolio includes DAXXIFY (DaxibotulinumtoxinA-lanm) for injection and the RHA Collection of dermal fillers in the United States. It has also partnered with Viatris to develop a biosimilar to onabotulinumtoxinA for injection and Fosun to commercialize DAXXIFY in China. Its product/product candidate includes DAXXIFY for glabellar lines indication; DAXXIFY for cervical dystonia indication; RHA Redensity for perioral rhytids indication; RHA 2/ RHA 3/ RHA 4 for facial wrinkles and folds (such as nasolabial folds) indication; DAXXIFY for forehead lines, lateral canthal lines, upper facial lines indication; DAXXIFY for upper limb spasticity indication, and onabotulinumtoxinA biosimilar. The Company has exclusive right to import, market, promote, sell and distribute Teoxane's line of Resilient Hyaluronic Acid dermal fillers.